PCVX – Vaxcyte, Inc.
Vaxcyte, Inc.PCVX
$85.30Name : Vaxcyte, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $10,631,536,640.00
EPSttm : -4.6
Vaxcyte, Inc.
$85.30
2.88%$2.53Float Short %
11.9
Margin Of Safety %
Put/Call OI Ratio
0.51
EPS Next Q Diff
-0.2
EPS Last/This Y
0.22
EPS This/Next Y
-0.42
Price
85.36
Target Price
149.89
Analyst Recom
1
Performance Q
-27.67
Relative Volume
1.31
Beta
0.98
Ticker: PCVX
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | PCVX | 86.17 | 0.69 | 0.00 | 12348 |
| 2024-12-20 | PCVX | 86.59 | 0.67 | 2.33 | 12250 |
| 2024-12-23 | PCVX | 87.03 | 0.58 | 1.02 | 10893 |
| 2024-12-24 | PCVX | 85.91 | 0.57 | 0.00 | 11046 |
| 2024-12-26 | PCVX | 85.68 | 0.58 | 0.00 | 11190 |
| 2024-12-27 | PCVX | 80.88 | 0.58 | 0.07 | 11180 |
| 2024-12-30 | PCVX | 81.97 | 0.57 | 17.89 | 11160 |
| 2024-12-31 | PCVX | 81.88 | 0.58 | 0.11 | 11255 |
| 2025-01-02 | PCVX | 83.33 | 0.53 | 5.00 | 10884 |
| 2025-01-03 | PCVX | 84.81 | 0.53 | 999.99 | 10895 |
| 2025-01-06 | PCVX | 86.05 | 0.54 | 999.99 | 10905 |
| 2025-01-07 | PCVX | 87.36 | 0.51 | 0.50 | 10718 |
| 2025-01-08 | PCVX | 81.05 | 0.51 | 1.63 | 10719 |
| 2025-01-09 | PCVX | 81.06 | 0.51 | 0.13 | 10719 |
| 2025-01-10 | PCVX | 81.13 | 0.41 | 0.04 | 11524 |
| 2025-01-13 | PCVX | 81.07 | 0.32 | 0.00 | 13451 |
| 2025-01-14 | PCVX | 78.21 | 0.32 | 0.34 | 13421 |
| 2025-01-15 | PCVX | 89.32 | 0.28 | 1.73 | 13833 |
| 2025-01-16 | PCVX | 87.82 | 0.55 | 1.14 | 20008 |
| 2025-01-17 | PCVX | 85 | 0.51 | 1.05 | 21073 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | PCVX | 86.18 | 42.6 | - | -3.96 |
| 2024-12-20 | PCVX | 86.57 | 42.6 | - | -3.96 |
| 2024-12-23 | PCVX | 87.08 | 44.3 | - | -3.92 |
| 2024-12-24 | PCVX | 85.91 | 44.3 | - | -3.92 |
| 2024-12-26 | PCVX | 85.78 | 44.3 | - | -3.92 |
| 2024-12-27 | PCVX | 80.91 | 44.3 | - | -3.92 |
| 2024-12-30 | PCVX | 82.00 | 44.3 | - | -3.92 |
| 2024-12-31 | PCVX | 81.85 | 44.3 | - | -3.92 |
| 2025-01-02 | PCVX | 83.32 | 44.3 | - | -3.92 |
| 2025-01-03 | PCVX | 84.85 | 44.3 | - | -3.92 |
| 2025-01-06 | PCVX | 86.04 | 44.3 | - | -3.92 |
| 2025-01-07 | PCVX | 87.25 | 44.3 | - | -3.92 |
| 2025-01-08 | PCVX | 81.06 | 44.3 | - | -3.92 |
| 2025-01-09 | PCVX | 81.06 | 44.3 | - | -3.92 |
| 2025-01-10 | PCVX | 81.13 | 44.3 | - | -3.92 |
| 2025-01-13 | PCVX | 81.10 | 44.3 | - | -3.92 |
| 2025-01-14 | PCVX | 78.23 | 44.3 | - | -3.92 |
| 2025-01-15 | PCVX | 89.29 | 44.3 | - | -3.92 |
| 2025-01-16 | PCVX | 87.77 | 44.3 | - | -3.92 |
| 2025-01-17 | PCVX | 85.36 | 45.5 | - | -3.92 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | PCVX | -7.17 | 13.68 | 9.17 |
| 2024-12-20 | PCVX | -7.17 | 13.68 | 9.17 |
| 2024-12-23 | PCVX | -6.98 | 13.64 | 9.17 |
| 2024-12-24 | PCVX | -6.98 | 13.64 | 9.17 |
| 2024-12-26 | PCVX | -6.79 | 13.64 | 10.47 |
| 2024-12-27 | PCVX | -6.70 | 13.64 | 10.47 |
| 2024-12-30 | PCVX | -7.07 | 12.77 | 10.47 |
| 2024-12-31 | PCVX | -7.07 | 12.77 | 10.47 |
| 2025-01-02 | PCVX | -6.71 | 12.77 | 10.47 |
| 2025-01-03 | PCVX | -6.56 | 12.77 | 10.47 |
| 2025-01-06 | PCVX | -6.60 | 13.64 | 10.47 |
| 2025-01-07 | PCVX | -6.60 | 13.64 | 10.47 |
| 2025-01-08 | PCVX | -6.82 | 13.64 | 10.47 |
| 2025-01-09 | PCVX | -6.82 | 13.64 | 10.47 |
| 2025-01-10 | PCVX | -6.72 | 13.64 | 10.47 |
| 2025-01-13 | PCVX | -6.72 | 13.62 | 11.90 |
| 2025-01-14 | PCVX | -6.72 | 13.62 | 11.90 |
| 2025-01-15 | PCVX | -6.72 | 13.62 | 11.90 |
| 2025-01-16 | PCVX | -6.72 | 13.62 | 11.90 |
| 2025-01-17 | PCVX | -6.74 | 13.62 | 11.90 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.83
Avg. EPS Est. Current Quarter
-1.01
Avg. EPS Est. Next Quarter
-1.03
Insider Transactions
-6.74
Institutional Transactions
13.62
Beta
0.98
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
13
Growth Score
20
Sentiment Score
93
Actual DrawDown %
29.5
Max Drawdown 5-Year %
Target Price
149.89
P/E
Forward P/E
PEG
P/S
P/B
3.11
P/Free Cash Flow
EPS
-4.68
Average EPS Est. Cur. Y
-3.92
EPS Next Y. (Est.)
-4.35
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
1.31
Return on Equity vs Sector %
-33.9
Return on Equity vs Industry %
-21.3
EPS 1 7Days Diff
EPS 1 30Days Diff
0.04
EBIT Estimation
Vaxcyte, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 254
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
stock quote shares PCVX – Vaxcyte, Inc. Stock Price stock today
news today PCVX – Vaxcyte, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch PCVX – Vaxcyte, Inc. yahoo finance google finance
stock history PCVX – Vaxcyte, Inc. invest stock market
stock prices PCVX premarket after hours
ticker PCVX fair value insiders trading